Crystal Structures of an Enantioselective Fab-Fragment in Free and Complex Forms.
Parkkinen, T., Nevanen, T.K., Koivula, A., Rouvinen, J.(2006) J Mol Biol 357: 471
- PubMed: 16427081
- DOI: https://doi.org/10.1016/j.jmb.2005.12.045
- Primary Citation of Related Structures:
2C1O, 2C1P - PubMed Abstract:
Enantioselective antibodies can separate the enantiomers of a chiral compound in a highly specific manner. We have recently reported the cloning and applications of a recombinant Fab-fragment, ENA11His, in the enantioseparation of a drug candidate, finrozole, which contains two chiral centers. Here, the crystal structures of this enantioselective antibody Fab-fragment are determined in the absence of the hapten at a resolution of 2.75 A, and in the presence of the hapten at 2.05 A resolution. The conformation of the protein was found to be similar in both free and complex forms. The hapten molecule was tightly bound in a deep cleft between the light and heavy chains of the Fab-fragment. The complex structure also allowed us to describe the molecular basis for enantioselectivity and to deduce the absolute configurations of all the four different stereoisomers (a-d) of finrozole. The ENA11His antibody fragment selectively binds the SR (a) enantiomer from the racemic mixture of a and d-enantiomers, thus allowing separation from the pharmacologically most active RS enantiomer (d). In particular, Asp95 and Asn35 of the H-chain in the ENA11 His antibody seem to provide this specificity through hydrogen bonding.
Organizational Affiliation:
Department of Chemistry, University of Joensuu, PO Box 111, FIN-80101 Joensuu, Finland.